Masima transforms traditionally subjective brain imaging into standardised, data-driven diagnostics through proprietary AI models trained on local clinical data. As the first Brazilian healthtech to deliver quantitative neuroimaging reports across MRI, CT, and PET, Masima provides clinically validated reports in Portuguese, with local support and up to three times lower cost than imported alternatives.

Its cloud-based, infrastructure-free solution integrates into existing clinical workflows, enabling healthcare providers, including those in resource-constrained settings, to access advanced neuroimaging capabilities and improve early diagnosis of neurological diseases such as Alzheimer’s.